Newborn Screening Equity in Spain: Progress and Persistent Gaps
International Journal of Neonatal Screening · 18.11.2026 · 12 (4) · 103
DOI: 10.3390/ijns12040103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 18.11.2026. Verfasst von Raquel Yahyaoui. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Newborn screening (NBS) in Spain has evolved from regionally developed programmes towards an increasingly harmonised national framework. However, differences in screening panels, implementation, and programme performance persist within its decentralised health system. This study examines the evolution of Spanish NBS and the implications of territorial variation, programme performance, and recent policy developments for equity. I conducted a descriptive documentary analysis of historical and scientific publications, national legislation, Ministry of Health programme evaluations for 2016–2024, official regional information, and selected patient-organization and stakeholder materials. A condition-by-territory dataset was compiled for the 17 autonomous communities and the autonomous cities of Ceuta and Melilla, comprising 83 condition entries classified according to their documented screening status. The territorial compilation identified 22–48 primary condition entries per territory, with additional heterogeneity in the classification of secondary findings. In 2024, NBS participation exceeded 99.5%; sample-collection timing met the national acceptable or optimal criteria in 16/19 territories and transport timing in 9/19, while individual follow-up information covered approximately 55% of confirmed cases. The common national portfolio expanded to 21 conditions in 2026, accompanied by a new framework for periodic evaluation and updating. The documentary analysis also identified increasing societal mobilisation around NBS, bringing territorial differences and delayed diagnosis into the wider public and policy debate. Regional innovation and emerging genomic approaches add further dimensions to the relationship between innovation and equity. Spain has made substantial progress towards a more harmonised NBS system, but equity cannot be assessed by panel composition alone. It requires comparable implementation, timely confirmation and treatment, robust follow-up and sustainable clinical pathways. Future governance should combine national harmonisation with opportunities for evidence-generating regional innovation, transparent evaluation and meaningful societal participation. These principles will become increasingly important as NBS expands and genomic screening moves closer to clinical implementation.
Zitieren
APA
Yahyaoui, R. (2026). Newborn Screening Equity in Spain: Progress and Persistent Gaps. International Journal of Neonatal Screening, 12(4), 103. https://doi.org/10.3390/ijns12040103
Vancouver
Yahyaoui R. Newborn Screening Equity in Spain: Progress and Persistent Gaps. International Journal of Neonatal Screening. 2026;12(4):103. doi:10.3390/ijns12040103
BibTeX
@article{Yahyaoui2026,
author = {Yahyaoui, Raquel},
title = {Newborn Screening Equity in Spain: Progress and Persistent Gaps},
journal = {International Journal of Neonatal Screening},
year = {2026},
volume = {12},
number = {4},
pages = {103},
doi = {10.3390/ijns12040103}
}
EUVIMED